NKTR DEADLINE ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Nektar Therapeutics - NKTR
NEW YORK, NY / ACCESSWIRE / September 10, 2019 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Nektar Therapeutics (NKTR) from February 15, 2019 through August 8, 2019 inclusive (the “Class Period”). The lawsuit seeks to recover damages for Nektar investors under the federal securities laws.
To join the class action, go to http://pawarlawgroup.com/cases/nektar-therapeutics/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 18, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) that the Company did not comply with current good manufacturing practices; (2) that, as a result, batches of NKTR-214 were not produced consistently and differed meaningfully; (3) that clinical results from PIVOT-02 differed based on the batch of NKTR-214 used in the study; (4) that, as a result, the PIVOT-02 study did not produce statistically significant results to support a finding of clinical benefit; and (5) as a result, Nektar’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.
Pawar Law Group represents investors from around the world.
-------------------------------
Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com
SOURCE: Pawar Law Group
View source version on accesswire.com:
https://www.accesswire.com/559064/NKTR-DEADLINE-ALERT-Pawar-Law-Group-Announces-a-Securities-Class-Action-Lawsuit-Against-Nektar-Therapeutics--NKTR
